NEW STUDY Association between variables measured in the ambulance and in-hospital mortality among adult patients with and without infection: a prospective cohort study Conclusions: suPAR ≥ 8.0 ng/mL was associated with mortality in patients [...]
NEW STUDY Self‑rated health and chronic infammation are related and independently associated with hospitalization and long‑term mortality in the general population Results Relationship between SRH and suPAR levels. The participants had a median suPAR [...]
NEW STUDY Soluble Urokinase Plasminogen Activator Receptor Levels and Outcomes in Patients with Heart Failure Conclusion suPAR levels are higher in HF compared to non-HF, are strongly predictive of outcomes, and combined with BNP, [...]
STUDY Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosis People with kidney disease are disproportionately affected by atherosclerosis for unclear reasons. Soluble urokinase plasminogen activator receptor (suPAR) is an immune-derived [...]
NEW STUDY Soluble urokinase-type plasminogen activator receptor improves early risk stratification in cardiogenic shock Conclusion SuPAR associates with mortality and improves risk stratification independently of other previously known risk factors in CS patients. Aims Soluble [...]
NEW STUDY Soluble urokinase plasminogen activator receptor and decline in kidney function among patients without kidney disease Conclusion A higher suPAR level was associated with accelerated eGFR decline among patients presenting to the emergency [...]
NEW STUDY suPAR: An Inflammatory Mediator for Kidneys Conclusion The last 10 years of research has established suPAR as a unique inflammatory mediator for kidneys. While open questions remain and deserve additional studies, modulating [...]
NEW STUDY Soluble urokinase Plasminogen Activator Receptor (suPAR) levels are predictive of COVID-19 severity: an Italian experience Conclusion suPAR levels correlate with disease severity and survival rate of COVID-19 patients, representing a promising prognostic [...]
38 hospitals use suPAR in clinical routine for triage of patients in the Emergency Departments and COVID-19 units. Clinical routine is defined by the placement of two Purchasing Orders within the last 12 months rolling. This period covers October 1, 2021, until September 30, 2022.
Some hospital locations cannot be disclosed due to confidentiality.
New Webinar
